Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Antidilutive Shares (Details)

v3.22.1
Net Loss Per Share - Schedule of Antidilutive Shares (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 11, 2021
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Proceeds from issuance of convertible debt, net of issuance costs   $ 0 $ 334,410
Capped Call Transactions      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Proceeds from issuance of convertible debt, net of issuance costs $ 29,300    
Offering price per share (in dollars per share)   $ 85.75  
Stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares)   467,000 2,418,000
Restricted Stock      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares)   137,000 216,000
Convertible Debt Securities | 1.25% Convertible Senior Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares)   5,538,000 5,538,000
Convertible Debt Securities | 0.25% Convertible Senior Notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities (in shares)   5,215,000 4,868,000